a b c
d e f
g h i
j k l
m n o
p q r s
t u v
w x y z
a b c
d e f
g h i
j k l
m n o
p q r s
t u v
w x y z
|
|
|
|
|
Product |
Code |
Section |
|
Talin |
NCL-TALIN |
Special Interest |
|
Tartrate-Resistant Acid Phosphatase |
NCL-TRAP |
Special Interest |
|
Tau |
NCL-Tau-2 |
Neural Tissue and Tumour Markers |
|
Tau and Beta Amyloid Antibodies (duo pack) |
NCL-B-Amy/Tau-2 |
Neural Tissue and Tumour Markers |
|
T Cell Antigen Receptor (JOVI 1) |
NCL-JOVI 1 |
Lymphoid Markers |
|
T Cell Antigen Receptor (JOVI 3) |
NCL-JOVI 3 |
Lymphoid Markers |
|
Telomerase (Catalytic Unit) |
NCL-hTERT |
Cell Cycle Associated Markers |
|
Tenascin |
NCL-TENASCIN |
Special Interest |
|
Terminal Deoxynucleotidyl Transferase |
NCL-TdT-339 |
Lymphoid Markers |
|
Terminal Deoxynucleotidyl Transferase (Liquid Primary Antibody) |
NCL-L-TdT-339 |
Lymphoid Markers |
|
Terminal Deoxynucleotidyl Transferase (Ready to Use) |
RTU-TdT-339 |
Lymphoid Markers |
|
Terminal Deoxynucleotidyl Transferase |
NCL-TdT |
Lymphoid Markers |
|
Tetranectin |
NCL-T-NECTIN |
Tumour Markers |
|
Thrombomodulin (CD141) |
NCL-CD141 |
Cluster Differentiation Markers |
|
Thrombomodulin (CD141) |
NCL-THROMBO |
Cluster Differentiation Markers |
|
Thyroglobulin |
NCL-THY |
Hormones |
|
Thyroglobulin (Liquid Primary Antibody) |
NCL-L-THY |
Hormones |
|
Thyroid Stimulating Hormone |
NCL-TSH |
Hormones |
|
Thyroid Stimulating Hormone Receptor |
NCL-TSH-R |
Hormone Receptors and Estrogen Regulated Proteins |
|
Thyroid Stimulating Hormone Receptor |
NCL-TSH-R2 |
Hormone Receptors and Estrogen Regulated Proteins |
|
Thyroid Transcription Factor-1 |
NCL-TTF-1 |
Tumour Markers |
|
Thyroid Transcription Factor-1 (Liquid Primary Antibody) |
NCL-L-TTF-1 |
Tumour Markers |
|
Tissue Adhesive, Novobond Slide |
NCL-BOND |
Secondary Detection Systems and Reagents |
|
Tissue Inhibitor of Matrix Metalloproteinase 1 |
NCL-TIMP1 |
Tumour Markers |
|
Tissue Inhibitor of Matrix Metalloproteinase 2 |
NCL-TIMP2 |
Tumour Markers |
|
TNFR-Associated Death Domain Protein |
NCL-TRADD |
Cell Cycle Associated Markers |
|
TNF-Related Apoptosis Inducing Ligand |
NCL-TRAIL |
Cell Cycle Associated Markers |
|
Topoisomerase I |
NCL-TOPO I |
Cell Cycle Associated Markers |
|
Topoisomerase II Alpha |
NCL-TOPOIIA |
Cell Cycle Associated Markers |
|
Topoisomerase II Alpha |
NCL-TOPOIIAp |
Cell Cycle Associated Markers |
|
Topoisomerase II Beta |
NCL-TOPOIIB |
Cell Cycle Associated Markers |
|
Topoisomerase III Alpha |
NCL-TOPOIIIA |
Cell Cycle Associated Markers |
|
Toxoplasma gondii P30 antigen |
NCL-TG |
Microbiology/Virology |
|
Transferrin Receptor (CD71) |
NCL-CD71-309 |
Cluster Differentiation Markers |
|
Transforming Growth Factor Beta |
NCL-TGFB |
Growth Factors and Receptors |
|
Transforming Growth Factor Beta Receptor (type 1) |
NCL-TGFBR1 |
Growth Factors and Receptors |
|
Troponin C |
NCL-TROPC |
Muscle Disease |
|
Troponin T |
NCL-TROPT |
Muscle Disease |
|
Tryptophan Hydroxylase |
NCL-TRYPH |
Neural Tissue and Tumour Markers |
|
Tuberin |
NCL-TUBERIN |
Special Interest |
|
Tumour Associated Mucin Antigen (CA242) |
NCL-CA242 |
Tumour Markers |
|
Tyrosinase |
NCL-TYROS |
Tumour Markers |
|
Tyrosinase (Liquid Primary Antibody) |
NCL-L -TYROS |
Tumour Markers |
|
Tyrosinase (Ready to Use) |
RTU-TYROS |
Tumour Markers |
|
Tyrosinase-Related Protein-1 |
NCL-TRP-1 |
Tumour Markers |
|
Tyrosine Hydroxylase |
NCL-TH |
Neural Tissue and Tumour Markers |
